Akili (AKLI) Competitors

In the previous week, Hyperfine had 5 more articles in the media than Akili. MarketBeat recorded 5 mentions for Hyperfine and 0 mentions for Akili. Hyperfine's average media sentiment score of 0.36 beat Akili's score of 0.00 indicating that Hyperfine is being referred to more favorably in the media.

Hyperfine has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Comparatively, Akili has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500.

15.0% of Hyperfine shares are held by institutional investors. Comparatively, 53.1% of Akili shares are held by institutional investors. 26.3% of Hyperfine shares are held by company insiders. Comparatively, 10.1% of Akili shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Hyperfine has higher revenue and earnings than Akili. Hyperfine is trading at a lower price-to-earnings ratio than Akili, indicating that it is currently the more affordable of the two stocks.

Hyperfine has a net margin of -262.29% compared to Akili's net margin of -2,492.04%. Akili's return on equity of -79.93% beat Hyperfine's return on equity.

Hyperfine currently has a consensus target price of $1.59, indicating a potential downside of 8.24%. Given Hyperfine's stronger consensus rating and higher probable upside, equities research analysts clearly believe Hyperfine is more favorable than Akili.

53.1% of Akili shares are owned by institutional investors. Comparatively, 62.7% of Edap Tms shares are owned by institutional investors. 10.1% of Akili shares are owned by company insiders. Comparatively, 0.2% of Edap Tms shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Edap Tms has a net margin of -41.24% compared to Akili's net margin of -2,492.04%. Akili's return on equity of -79.93% beat Edap Tms' return on equity.

Edap Tms has a consensus target price of $6.00, indicating a potential upside of 66.67%. Given Edap Tms' stronger consensus rating and higher possible upside, analysts clearly believe Edap Tms is more favorable than Akili.

In the previous week, Edap Tms had 3 more articles in the media than Akili. MarketBeat recorded 3 mentions for Edap Tms and 0 mentions for Akili. Edap Tms' average media sentiment score of 0.47 beat Akili's score of 0.00 indicating that Edap Tms is being referred to more favorably in the news media.

Akili has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Edap Tms has a beta of -0.1, indicating that its share price is 110% less volatile than the S&P 500.

Edap Tms has higher revenue and earnings than Akili. Edap Tms is trading at a lower price-to-earnings ratio than Akili, indicating that it is currently the more affordable of the two stocks.

In the previous week, Solana had 3 more articles in the media than Akili. MarketBeat recorded 3 mentions for Solana and 0 mentions for Akili. Solana's average media sentiment score of 0.86 beat Akili's score of 0.00 indicating that Solana is being referred to more favorably in the media.

Solana presently has a consensus target price of $3.50, suggesting a potential upside of 57.66%. Given Solana's stronger consensus rating and higher possible upside, equities research analysts clearly believe Solana is more favorable than Akili.

18.6% of Solana shares are held by institutional investors. Comparatively, 53.1% of Akili shares are held by institutional investors. 14.4% of Solana shares are held by insiders. Comparatively, 10.1% of Akili shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Solana has higher revenue and earnings than Akili. Akili is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Solana has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Akili has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500.

Solana has a net margin of -679.54% compared to Akili's net margin of -2,492.04%. Akili's return on equity of -79.93% beat Solana's return on equity.

Neuronetics has a net margin of -24.48% compared to Akili's net margin of -2,492.04%. Akili's return on equity of -79.93% beat Neuronetics' return on equity.

In the previous week, Neuronetics had 9 more articles in the media than Akili. MarketBeat recorded 9 mentions for Neuronetics and 0 mentions for Akili. Neuronetics' average media sentiment score of 0.35 beat Akili's score of 0.00 indicating that Neuronetics is being referred to more favorably in the media.

Neuronetics presently has a consensus target price of $3.00, suggesting a potential upside of 57.07%. Given Neuronetics' stronger consensus rating and higher possible upside, equities research analysts clearly believe Neuronetics is more favorable than Akili.

Neuronetics has higher revenue and earnings than Akili. Neuronetics is trading at a lower price-to-earnings ratio than Akili, indicating that it is currently the more affordable of the two stocks.

Neuronetics has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Akili has a beta of 1.72, meaning that its stock price is 72% more volatile than the S&P 500.

53.6% of Neuronetics shares are held by institutional investors. Comparatively, 53.1% of Akili shares are held by institutional investors. 8.4% of Neuronetics shares are held by insiders. Comparatively, 10.1% of Akili shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.